Biological & Fonctional Signatures for Muscle Failures, Aged People & Personalized Physical Activity (BioFaSt)

November 25, 2025 updated by: Centre Hospitalier Universitaire de Nice

Biological & Fonctional Signatures for Muscle Failures, Aged People & Personalized Physical Activity : BioFaSt MAPPA

Physical activity is one of the most effective therapeutic interventions for frailty, sarcopenia or dynapenia. The benefits of physical activity processes are already widely documented. Typically, researchers want to understand the average response to an intervention to determine its overall effectiveness. However, sports trainers have understood it for a long time, the response of an athlete or a patient to training is very variable and the standard deviations present in all the scientific studies on the subject confirm it. There is therefore inter-individual variation in the response to exercise, with some subjects showing much greater improvements than others. Thus, one can wonder if this "non-response" following training is specific to the training modality. The effects of physical exercise on the body depend mainly on its type, intensity and duration. Thus, from a practical point of view, the most important perspective is the prediction and, ultimately, the individual optimization of management through physical activity.

Study Overview

Detailed Description

Main objective: To determine the effects of personalized physical activity management on the biological signatures of muscle failure.

Secondary objectives:

  • Propose a support system through adapted and individualized physical activity, based on physical, biological and psycho-social indicators
  • Identify the biological signatures (metabolomics, epigenetic) of muscle failure in the elderly.

Phenotype responders and non-responders in training

900 seniors (300 per group) APAP group: adapted and personalized physical activity APA group: adapted physical activity Control group: no physical activity

Total duration of the study 5 years, duration of participation for a patient 3 months; inclusion period: 57 months

Improvement of muscle failure in its broad definition (Strength, power, speed and lean mass)

) General data: description of characteristics with frequencies and percentage for categorical variables and with mean and standard deviation for quantitative variables.

ii) Analysis of the primary endpoint: Machine Learning (or supervised classification) and signaling pathway prediction approaches for statistical analysis and data interpretation.

iii) Analysis of secondary judgment criteria: approaches in Machine Learning (or supervised classification) and signaling pathway prediction for statistical analysis and interpretation of data with comparison of quantitative variables by Pearson correlation and categorical variables by t or chi 2 test depending on the case.

Adapt and individualize physical activity support for healthy or frail elderly people

Study Type

Interventional

Enrollment (Estimated)

900

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Nice, France, 06000
        • Recruiting
        • CHU de Nice
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

60 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Age greater than or equal to 60 years
  • Affiliated patient or beneficiary of a social security scheme
  • Patient having signed a prior informed consent.

Exclusion criteria

  • Neurocognitive disorder preventing the expression of informed consent
  • Patients protected by law under guardianship or curatorship, or who cannot participate in a clinical study under Article L. 1121-16 of the French Public Health Code
  • Presence of a physical or cognitive pathology preventing the performance of the adapted physical activity protocol over 3 months.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: APAP group: adapted and personalized physical activity
12 weeks of adapted and personalized physical activity
blood sample before and after 12 weeks of physical activity

physical assessement before and after 12 weeks of physical activity

  • Standardized geriatric assessment (physician visit)
  • ICOPE Monitor Assessment
  • Sit-to-stand Test
  • Quantified Gait Analysis (QAM)
  • Bone densitometer measurement of body composition

Psychometric questionnaires

  • Cognitive tests (MMSE)
  • The long questionnaire of personality traits: Big Five Inventory
  • Perceived health and subjective age
  • Age group identification
  • Attitudes towards aging: French version of the Attitudes Toward Own Aging scale
  • Physical self-perception: French version of the Physical Self-Perception Profile
  • MOTIVATION SCALE FOR PA FOR HEALTH PURPOSES: Motivation Scale for Physical Activity in a Health Context
  • Aging Stereotypes and Exercise Scale
Active Comparator: APA group: adapted physical activity
12 weeks of generic physical activity
blood sample before and after 12 weeks of physical activity

physical assessement before and after 12 weeks of physical activity

  • Standardized geriatric assessment (physician visit)
  • ICOPE Monitor Assessment
  • Sit-to-stand Test
  • Quantified Gait Analysis (QAM)
  • Bone densitometer measurement of body composition

Psychometric questionnaires

  • Cognitive tests (MMSE)
  • The long questionnaire of personality traits: Big Five Inventory
  • Perceived health and subjective age
  • Age group identification
  • Attitudes towards aging: French version of the Attitudes Toward Own Aging scale
  • Physical self-perception: French version of the Physical Self-Perception Profile
  • MOTIVATION SCALE FOR PA FOR HEALTH PURPOSES: Motivation Scale for Physical Activity in a Health Context
  • Aging Stereotypes and Exercise Scale
Sham Comparator: Control group: no physical activity
no physical activity
blood sample before and after 12 weeks of physical activity

physical assessement before and after 12 weeks of physical activity

  • Standardized geriatric assessment (physician visit)
  • ICOPE Monitor Assessment
  • Sit-to-stand Test
  • Quantified Gait Analysis (QAM)
  • Bone densitometer measurement of body composition

Psychometric questionnaires

  • Cognitive tests (MMSE)
  • The long questionnaire of personality traits: Big Five Inventory
  • Perceived health and subjective age
  • Age group identification
  • Attitudes towards aging: French version of the Attitudes Toward Own Aging scale
  • Physical self-perception: French version of the Physical Self-Perception Profile
  • MOTIVATION SCALE FOR PA FOR HEALTH PURPOSES: Motivation Scale for Physical Activity in a Health Context
  • Aging Stereotypes and Exercise Scale

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
muscle power
Time Frame: before and after 12 week of physical activity program
muscle power (Watt/Kg) assessed with the isokinetic ergometer.
before and after 12 week of physical activity program

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Different metabolomic signature (The amino acid composition) between the groups (APA, APAP, no physical activity)
Time Frame: at day 0
Change in the amino acid composition (metabolomic signature) at Day 0 between the groups
at day 0
Change in the amino acid composition (metabolomic signature) after 3 month of physical activity
Time Frame: between Day 0 and Month 3
Change in the amino acid composition (metabolomic signature) after 3 month of physical activity for the APA and APAP groups compared to the no physical activity group
between Day 0 and Month 3
ICOPE Monitor Assessment
Time Frame: before and after 12 week of physical activity program
Score of frailty. (Implementation of the Integrated Care of Older People, ICOPmonitor, 8 item, higher score means worse outcome)
before and after 12 week of physical activity program
Sit-to-stand Test
Time Frame: before and after 12 week of physical activity program
number of movement
before and after 12 week of physical activity program
Quantified Gait Analysis (QAM)
Time Frame: before and after 12 week of physical activity program
Gait velocity in m.s-1
before and after 12 week of physical activity program
Bone densitometer measurement of body composition
Time Frame: before and after 12 week of physical activity program
% of lean mass
before and after 12 week of physical activity program
Cognitive tests
Time Frame: before and after 12 week of physical activity program
Score Mini-Mental State Examination (MMSE, 0-30, higher score mean worse outcome)
before and after 12 week of physical activity program
The long questionnaire of personality traits
Time Frame: before and after 12 week of physical activity program
Score of Big Five Inventory, 0-44, higher score means worse outcome
before and after 12 week of physical activity program
Perceived health (Score of the scale)
Time Frame: before and after 12 week of physical activity program
Score of the scale, 0-6, higher score means better outcome
before and after 12 week of physical activity program
Subjective age
Time Frame: before and after 12 week of physical activity program
Subjective age in years
before and after 12 week of physical activity program
Age group identification (Years)
Time Frame: before and after 12 week of physical activity program
Age group identification in years
before and after 12 week of physical activity program
Attitudes towards aging
Time Frame: before and after 12 week of physical activity program
Score on the French version of the Attitudes Toward Own Aging scales, 0-7, higher score means better outcome
before and after 12 week of physical activity program
Physical self-perception
Time Frame: before and after 12 week of physical activity program
Score on the French version of the Physical Self-Perception Profile, 0-6, higher score means better outcome
before and after 12 week of physical activity program
Motivation scale for physical activity for health purposes
Time Frame: before and after 12 week of physical activity program
Score on the Motivation Scale for Physical Activity in a Health Context,0-30, higher score means better outcome
before and after 12 week of physical activity program
Aging Stereotypes and Exercise Scale
Time Frame: before and after 12 week of physical activity program
Score on the French Aging Stereotypes and Exercise Scale (ASES), 0-12, higher score means better outcome
before and after 12 week of physical activity program
Improvement of muscle force
Time Frame: before and after 12 week of physical activity program
Improvement of muscle force (N/Kg) assessed with the isokinetic ergometer.
before and after 12 week of physical activity program

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Olivier GUERIN, PU-PH, geriatric Department

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 29, 2022

Primary Completion (Estimated)

April 15, 2027

Study Completion (Estimated)

April 15, 2028

Study Registration Dates

First Submitted

March 2, 2022

First Submitted That Met QC Criteria

April 22, 2022

First Posted (Actual)

April 25, 2022

Study Record Updates

Last Update Posted (Estimated)

December 3, 2025

Last Update Submitted That Met QC Criteria

November 25, 2025

Last Verified

November 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Elderly

Clinical Trials on blood sample

Subscribe